Carregant...
Managing the risk of venous thromboembolism in transgender adults undergoing hormone therapy
Introduction: Venous thromboembolism (VTE) is a potential risk of estrogen therapy. However, data show an improvement in the quality of life for transgender people who use feminizing hormone therapy. With few transgender-specific data, guidance may be drawn from cisgender (nontransgender) data, with...
Guardat en:
| Publicat a: | J Blood Med |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6628137/ https://ncbi.nlm.nih.gov/pubmed/31372078 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JBM.S166780 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|